Monosaccharides

D-Talono-1,4-lactone is a stereoselective drug that inhibits the synthesis of c-glycosides and is used to study the mechanisms of action of these compounds. It has been shown to have antibacterial activity against gram-negative pathogens such as Escherichia coli, Salmonella typhi, Klebsiella pneumoniae, and Acinetobacter baumannii. D-Talono-1,4-lactone also has inhibitory activities against gram negative bacteria. This compound may be a potential biomarker for the detection of gram negative bacteria in water samples. The mechanism of action of this drug is not known but it is likely due to its ability to inhibit bacterial growth.

L-Mannonic acid-1,4-lactone is an acidic compound that has kinetic properties. It is used in the assays of chloride ions and neutral pH. L-Mannonic acid-1,4-lactone also has conjugates with hydrolytic activity and can be used as a synthetic intermediate for other organic compounds. L-Mannonic acid-1,4-lactone can be found in group P2 of the periodic table because it contains a hydroxyl group and an organic group with a methyl ethyl side chain. L-Mannonic acid-1,4-lactone hydrolyzes at high temperatures and may exhibit synergistic effects when combined with other agents. This product is also used to incubate cells such as k562 cells.

1,2,3,4-Tetra-O-acetyl-L-rhamnopyranose is an acetylated disaccharide that is glycosylated with mercuric triflate and glycoalkaloid acceptors. It has been shown to be a glycosylation coupling agent for theophylline in solanum species. 1,2,3,4-Tetra-O-acetyl-L-rhamnopyranose can also act as a steroidal glycoalkaloid acceptor and has been identified in Solanum species.

a-D-Galactopyranosyl phenylisothiocyanate is a compound that is used in the synthesis of saccharides and oligosaccharides. It reacts with a variety of sugars, including glucose, sucrose, maltose and lactose, to produce methylated derivatives. This reagent is also useful for the synthesis of glycosides. The product can be used in custom synthesis or as a fluorinated carbohydrate.

6-O-Acetylglycitin is a bioactive compound that has been shown to have many physiological activities. It is the acetylated form of glycitin, which is a precursor in the synthesis of glycogen in the liver. 6-O-Acetylglycitin has been shown to promote the repair mechanism of hepatic steatosis and exhibits anti-cancer effects by inhibiting poly(ADP-ribose) polymerase chain reaction (PCR) and uvb-induced polymerase chain reaction (PCR). This compound also inhibits growth of cancer cells in vitro. 6-O-Acetylglycitin has been shown to have an analog with pharmaceutical preparations.

L-Threose is a sugar molecule that is used as a structural component of DNA and RNA. It is also an important part of the energy metabolism in cells. L-Threose can be enzymatically inactivated by glycosidases, which are enzymes that hydrolyze glycosidic bonds. The inhibition of glycosidases by L-threose may be useful for the prevention or treatment of diseases associated with enzyme activity, such as diabetes mellitus type II. L-Threose has been shown to have inhibitory properties against sephadex G-100, a membrane protein found in bacteria. L-Threose may be useful as a control agent for research into the response element of polymerase chain reaction (PCR).

2-Formylphenyl b-D-glucopyranoside is a phenolic compound that has been shown to have high resistance to transport. It has been shown to possess surface methodology and this property can be used for the delivery of compounds. 2-Formylphenyl b-D-glucopyranoside has also been shown to inhibit plant enzyme activities such as detoxification enzymes and carbohydrate chemistry, which are important in the uptake of natural compounds. In addition, it is able to bind with amines and hydroxyl groups on cells, which may be due to its receptor cell properties. 2-Formylphenyl b-D-glucopyranoside can be synthesized by reacting trifluoroacetic acid with an amine and a hydroxyl group in the presence of glycol ethers or natural compounds.

N-Acetyl-3-fluoro-neuraminic acid sodium (AFNA) is an inhibitor that binds to the terminal sialic acid residue of the glycoprotein neuraminidase in influenza viruses, preventing the virus from attaching to cells. AFNA is a fluorinated derivative of mannosamine and is synthesized by reacting an aldolase with sulfur trifluoride. AFNA has been shown to inhibit sialidases and utilising enzymes, which are necessary for viral replication. AFNA also inhibits bacterial sialidases, which are required for the synthesis of cell wall components.

The interaction of 1,3,4,6-tetra-O-acetyl-2-deoxy-2-phthalimido-b-D-glucopyranoside with DNA is selective for the hydroxyl group and for the stacking of its glycosidic bonds. The data obtained from the spectra show that this compound interacts with the sugar moiety of nucleosides to yield a product with a lower melting point. The binding constants are high and the yields are low.

Competitive inhibitor of ceramide-glycosyltransferase used for substrate reduction therapy in lysosomal storage disorders. It inhibits glucosylceramide synthase, which catalyses the initial step in glycosphingolipid biosynthetic pathway. This compound delays the onset of symptoms in type 1 Gaucher disease, Sandhoff disease and Tay-Sachs disease. It also reduces brain abnormalities in mucolipidosis type IV.

5,6-O-Isopropylidene-phlorigidoside B is a glycosylation inhibitor that belongs to the class of oligosaccharides and synthetic compounds. This compound has been shown to inhibit the synthesis of complex carbohydrates by reacting with a phosphoryl group on an activated sugar. The 5,6-O-isopropylidene group on the molecule is fluorinated and methylated, which may be used for custom synthesis or modification. 5,6-O-Isopropylidene-phlorigidoside B can also be used as a fluorescent probe in fluorescence microscopy.

Fuculose is a monosaccharide that is a constituent of fucose-containing glycoproteins. It is found in the blood and urine, as well as in various tissues, such as liver, lung, kidney, and spleen. The biological properties of L-fuculose are related to its ability to form hydrogen bonds with other molecules. Fuculose has been shown to be an effective activator for cutaneous lesions in mice models. The structural analysis of L-fuculose has revealed that it contains a reactive site for the synthesis of glycosaminoglycans and polysaccharides. Fuculose has also been shown to increase the proliferation of some cells, including corynebacterium glutamicum and human umbilical vein endothelial cells (HUVECs). This property may be due to its ability to activate growth factors or interfere with cell signaling pathways.

L-Glucono-1,4-lactone is a substance that belongs to the group of compounds known as alpha hydroxy acids. It is produced in the body by an enzyme called l-gluconolactonase and is present in small quantities in many fruits and vegetables. L-Glucono-1,4-lactone has been shown to prevent skin aging and protect against UV light damage through its antioxidant properties. This compound can be found in sunscreens or it can be taken orally to provide protection from the sun. Clinical data on L-Glucono-1,4-lactone treatments are not yet available.

N-[2-(4'-Methoxyphenylacetonitrile)]-2,3,4,6-tetra-O-pivaloyl-D-glucopyranoside is a custom synthesis of a carbohydrate. It is a synthetic saccharide that is modified by fluorination and methylation. This compound has high purity and can be custom synthesized to order.

3-O-Benzyl-2-deoxy-D-arabinopyranose is a modified sugar that can be used in the synthesis of oligosaccharides. It is a white powder that has a purity level of more than 99%. The CAS number for 3-O-Benzyl-2-deoxy-D-arabinopyranose is 52397-07-8. This product can be custom synthesized to meet your specific needs. It can also be methylated, glycosylated, or modified with a click chemistry reaction.